Cargando…

Pharmacy and Medical Costs Associated With Switching Between Venlafaxine and SSRI Antidepressant Therapy for the Treatment of Major Depressive Disorder

BACKGROUND: While much has been published on utilization of antidepressants and associated resource use, surprisingly little information is available on the relationship between a change in antidepressant agent and health care utilization. Given that many patients will not respond to initial therapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khandker, Rezaul K., Kruzikas, Denise T., McLaughlin, Trent P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438018/ https://www.ncbi.nlm.nih.gov/pubmed/18597572 http://dx.doi.org/10.18553/jmcp.2008.14.5.426

Ejemplares similares

The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder
por: Sobocki, P, et al.
Publicado: (2008)

Study of antinociceptive activity of SSRI (fluoxetine and escitalopram) and atypical antidepressants (venlafaxine and mirtazepine) and their interaction with morphine and naloxone in mice
por: Sikka, Pranav, et al.
Publicado: (2011)

Learning from negative feedback in patients with major depressive disorder is attenuated by SSRI antidepressants
por: Herzallah, Mohammad M., et al.
Publicado: (2013)

Antidepressant therapy with milnacipran and venlafaxine
por: Mansuy, Lucilla
Publicado: (2010)

Strategy to Accelerate or Augment the Antidepressant Response and for An Early Onset of SSRI Activity. Adjunctive Amisulpride to Fluvoxamine in Major Depressive Disorder
por: Hardoy, Maria Carolina, et al.
Publicado: (2010)

Modulation of microglial function by the antidepressant drug venlafaxine
por: Dubovický, Michal, et al.
Publicado: (2014)

Interferon-induced depressive illness in hep C patients responds to SSRI antidepressant treatments
por: Gupta, Ramesh K, et al.
Publicado: (2006)

Uncontrolled Self-Medication with Venlafaxine in a Patient with Major Depressive Disorder
por: Song, Ji-Hye, et al.
Publicado: (2011)

Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder
por: Ye, Wenyu, et al.
Publicado: (2011)

Identification of SSRI-evoked antidepressant sensory signals by decoding vagus nerve activity
por: West, Christine L., et al.
Publicado: (2021)

Risks of using SSRI / SNRI antidepressants during pregnancy and lactation
por: Dubovicky, Michal, et al.
Publicado: (2017)

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer
por: Ashbury, Janet E., et al.
Publicado: (2012)

Clinical characteristics associated with the prescribing of SSRI medication in adolescents with major unipolar depression
por: Cousins, Lesley, et al.
Publicado: (2016)

Response to SSRI intervention and amygdala activity during self-referential processing in major depressive disorder
por: Young, Kymberly D., et al.
Publicado: (2020)

Venlafaxine treatment reduces the deficit of executive control of attention in patients with major depressive disorder
por: Tian, Yanghua, et al.
Publicado: (2016)

Meaning and medication: a thematic analysis of depressed adolescents’ views and experiences of SSRI antidepressants alongside psychological therapies
por: Maroun, Rita A., et al.
Publicado: (2018)

Highly polygenic architecture of antidepressant treatment response: Comparative analysis of SSRI and NRI treatment in an animal model of depression
por: Malki, Karim, et al.
Publicado: (2016)

Recent Advances in the Electrochemical Sensing of Venlafaxine: An Antidepressant Drug and Environmental Contaminant
por: Tajik, Somayeh, et al.
Publicado: (2020)

Comparison of duloxetine and SSRI as a treatment option of painful physical symptoms associated with major depressive disorder
por: Haider, Miqdad, et al.
Publicado: (2017)

Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a “real-world” chart review study
por: De Berardis, Domenico, et al.
Publicado: (2020)

Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants
por: Ben-Sheetrit, Joseph, et al.
Publicado: (2023)

Antidepressant emergent mood switch in major depressive disorder: onset, clinical correlates and impact on suicidality
por: Olgiati, Paolo, et al.
Publicado: (2023)

5-HTR1A and 5-HTR2A genetic polymorphisms and SSRI antidepressant response in depressive Chinese patients
por: Dong, Zai-Quan, et al.
Publicado: (2016)

Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity
por: Lyndon, Gavin J., et al.
Publicado: (2019)

Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder
por: Aldosary, Fahad, et al.
Publicado: (2021)

Augmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI Switch
por: Binkhorst, Lisette, et al.
Publicado: (2015)

Combined Venlafaxine and Olanzapine Prescription in Women with Psychotic Major Depression: A Case Series
por: Ghio, Lucio, et al.
Publicado: (2011)

Discontinuation Rates and Health Care Costs in Adult Patients Starting Generic Versus Brand SSRI or SNRI Antidepressants in Commercial Health Plans
por: Kautzner, Adam, et al.
Publicado: (2011)

Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use
por: Foletto, Vitória Segabinazzi, et al.
Publicado: (2022)

The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank
por: Wong, Win Lee Edwin, et al.
Publicado: (2023)

Organic cation transporter 2 contributes to SSRI antidepressant efficacy by controlling tryptophan availability in the brain
por: Orrico-Sanchez, Alejandro, et al.
Publicado: (2023)

The Influence of Acute SSRI Administration on White Matter Microstructure in Patients Suffering From Major Depressive Disorder and Healthy Controls
por: Seiger, R, et al.
Publicado: (2021)

Should antidepressants be used for major depressive disorder?
por: Jakobsen, Janus Christian, et al.
Publicado: (2020)

Multiple Stressors in the Environment: The Effects of Exposure to an Antidepressant (Venlafaxine) and Increased Temperature on Zebrafish Metabolism
por: Mehdi, Hossein, et al.
Publicado: (2019)

Effects of SSRI Antidepressants on Attentional Bias toward Emotional Scenes in First-Episode Depressive Patients: Evidence from an Eye-Tracking Study
por: Zhang, Lei, et al.
Publicado: (2020)

Effect of vortioxetine versus venlafaxine on cognitive functions in adults with major depressive disorder: A randomized-controlled trial
por: Manna, Chayan K., et al.
Publicado: (2023)

The SSRI Clinic: Improving SSRI Prescribing Safety in Outpatient CAMHS Clinic
por: Morgan, Tammy, et al.
Publicado: (2022)

Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder
por: Ta, Jamie T, et al.
Publicado: (2021)

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
por: Biernacka, J M, et al.
Publicado: (2015)

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
por: Biernacka, J M, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h146frlcqtqsaad4li819kgl4p